Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. - Dizman N; Meza L; Bergerot P; Alcantara M; Dorff T; Lyou Y; Frankel P; Cui Y; Mira V; Llamas M; Hsu J; Zengin Z; et al. (Nature medicine, 2022)